Search

GlaxoSmithKline PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

1,766 -0.03

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1738

Max

1789

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.4B

435M

Pardavimai

780M

8.4B

P/E

Sektoriaus vid.

14.907

47.946

Pelnas, tenkantis vienai akcijai

0.51

Dividendų pajamingumas

3.82

Pelno marža

5.173

Darbuotojai

66,841

EBITDA

-153M

2.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+18.19% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

3.82%

2.27%

Kitas uždarbis

2026-10-28

Kitas dividendų mokėjimo data

2027-01-07

Kita Ex Dividend data

2026-11-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-8.1B

70B

Ankstesnė atidarymo kaina

1766.03

Ankstesnė uždarymo kaina

1766

Naujienos nuotaikos

By Acuity

18%

82%

35 / 340 reitingas Healthcare

GlaxoSmithKline PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-08 23:51; UTC

News

Brookdale Senior Living reported a 130 basis point increase in occupancy to 83.1% for Q3 2026, but shares declined in after-market hours.

2026-10-08 23:46; UTC

News

KKR shares are advancing as Refresco considers an IPO potentially valuing the firm at over $10 billion; KKR Capital Corp announced a $0.44 quarterly distribution.

2026-10-08 23:42; UTC

Social Media
News

Ginkgo Bioworks to provide in-kind access to its Boston lab for the National Science Foundation’s $1.5 billion X-Labs program supporting independent research teams.

2026-10-08 23:30; UTC

News

Pacira Biosciences shares declined in after-market hours following a downgrade by Jefferies to Hold, with a price target set at $36.

2026-10-08 23:30; UTC

News

Chipotle Mexican Grill Inc's stock advanced amid reports that Starbucks is considering a potential acquisition, with advisers enlisted for what could be a historic deal.

2026-10-08 23:30; UTC

News

Walt Disney Company is in talks with rival studios about its Infinity Vision format to compete with Imax, despite shares trading lower.

2026-10-08 23:20; UTC

News

Immersion Corp CEO Eric Singer acquired 41k shares for approximately $292.8K on October 7, according to a regulatory filing.

2026-10-08 23:15; UTC

News

Cleveland-Cliffs shares advanced in after-market trading as CEO Lourenco Goncalves discussed potential steelworker recalls tied to a Canada-U.S. trade deal.

2026-10-08 23:11; UTC

News

Abcellera Biologics to present Phase 1/2 data for investigational drug ABCL635 at The Menopause Society's Annual Meeting in October.

2026-10-08 23:10; UTC

News

Citigroup downgraded Universal Display Corp to Sell and lowered its price target to $71, contributing to investor caution ahead of earnings.

2026-10-08 23:10; UTC

News

JP Morgan maintains Underweight rating on Kennametal Inc and lowers price target to $30, contributing to a decline in the stock during after-market hours.

2026-10-08 23:10; UTC

News

Barclays initiates Equalweight coverage with $554 target.

2026-10-08 23:05; UTC

News

Boeing Co shares gained in after-market hours after Barclays initiated coverage with an Overweight rating and a price target of $300.

2026-10-08 23:05; UTC

News
Correlated Moves

HubSpot Inc. declines in after-market trading following a downgrade from JP Morgan, which lowered its rating to Neutral and price target to $240.

2026-10-08 23:05; UTC

News

Barclays initiates coverage on Joby Aviation with an Underweight rating and a price target of $4.00, contributing to recent declines in after-market trading.

2026-10-08 23:05; UTC

News

USD/CZK declines modestly following U.S. jobless claims data showing initial claims fell to 197k, indicating ongoing labor market strength amid broader economic concerns.

2026-10-08 23:01; UTC

Social Media
News
Event

Park Aerospace Corp reported second-quarter net sales of $20.79 million and net earnings of $4.53 million, exceeding expectations amid strong demand in aerospace sectors.

2026-10-08 23:01; UTC

News

Over 69% of Medicare Advantage members in high-rated plans for 2027

2026-10-08 23:01; UTC

Social Media
News

Alignment Healthcare's stock declined sharply after a downgrade of its largest California contract's Medicare Advantage Star Rating from 4 stars to 3.5 stars.

2026-10-08 23:01; UTC

News

JP Morgan maintains Neutral rating on Deere & Co, raises price target to $625, reflecting a cautious outlook on the company's performance.

2026-10-08 23:01; UTC

News

Moomoo launches 24/7 account deposits via Apple Pay and Google Pay through a partnership with Visa and Checkout.com to enhance user funding capabilities.

2026-10-08 23:01; UTC

News

Citigroup downgraded Xerox Holdings Corp to Sell and lowered its price target to $2.50, citing concerns over performance and market position.

2026-10-08 23:01; UTC

News
Social Media
Correlated Moves

Verizon shares fell sharply in after-hours trading, attributed to competitive pressures from SpaceX's spectrum license acquisition and AT&T's notable drop.

2026-10-08 23:01; UTC

Social Media
News

American Express faces regulatory scrutiny and agrees to a $350 million penalty for anti-money laundering deficiencies related to $13 billion in suspected activity.

2026-10-08 23:01; UTC

News

USD/ZAR declines as U.S. jobless claims show a four-week average of 198k, slightly down from 200.5k.

2026-10-08 23:01; UTC

Social Media
News

RTX Corp awarded a five-year contract worth up to $6.3 billion for Standard Missile-3 Block IB interceptors, announced by Raytheon.

2026-10-08 23:01; UTC

News

Humana's largest Medicare Advantage contract improved to 4 stars in the 2027 ratings, reinstating eligibility for federal quality bonus payments.

2026-10-08 23:01; UTC

News

DICK'S Sporting Goods faces a class action lawsuit for failing to disclose material information, with Kahn Swick & Foti, LLC urging affected shareholders to file by November 3, 2026.

2026-10-08 23:00; UTC

News

Citigroup maintains a Buy rating on Arista Networks and raises its price target to $248, according to a report published today.

2026-10-08 22:50; UTC

Social Media
News

Starbucks explored a potential acquisition of Chipotle, valued at $41 billion, but analysts express skepticism about the strategic rationale amid ongoing turnaround efforts.

Akcijų palyginimas

Kainos pokytis

GlaxoSmithKline PLC Prognozė

Kainos tikslas

By TipRanks

18.19% į viršų

12 mėnesių prognozė

Vidutinis 2,116.25 GBX  18.19%

Aukščiausias 3,010 GBX

Žemiausias 1,700 GBX

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines GlaxoSmithKline PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

15 ratings

3

Pirkti

9

Laikyti

3

Parduoti

Rinkos nuotaikos

By Acuity

35 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.